+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID05463757

Study of Oral Hedgehog Inhibitors Vismodegib and Sonidegib for Treating Advanced and Multiple Basal Cell Carcinoma in the Netherlands

Led by Maastricht University Medical Center · Updated on 2025-04-04

80

Participants Needed

8

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of oral hedgehog inhibitors, vismodegib and sonidegib, for treating locally advanced basal cell carcinoma laBCC, metastatic basal cell carcinoma mBCC, and basal cell nevus syndrome BCNS patients. This prospective registration study in the Netherlands aims to evaluate the effectiveness of these drugs and compare their outcomes, as no direct comparative studies have been performed yet. The study gathers detailed patient, tumor, and treatment data to better understand these therapies.

CONDITIONS

Brief Title

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Research Team

E

Emmy Cruts, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here